EFEMP2 Antibody (C-term) Blocking Peptide

Background:
A large number of extracellular matrix proteins have been found to contain variations of the epidermal growth factor (EGF) domain and have been implicated in functions as diverse as blood coagulation, activation of complement and determination of cell fate during development. EFEMP2 contains four EGF2 domains and six calcium-binding EGF2 domains.

Other Names:
EGF-containing fibulin-like extracellular matrix protein 2, Fibulin-4, FIBL-4, Protein UPH1, EFEMP2, FBLN4

Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP8830a was selected from the C-term region of human EFEMP2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Gene Name: EFEMP2 (HGNC:3219)

Gene ID: 30008
Primary Accession: O95967
Other Accession: NP_058634
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.